Press release
Steady Growth Anticipated for Global G-CSF Market Fueled by Increasing Prevalence of Cancer and Demand for Innovative Drugs
G-CSF (Granulocyte Colony Stimulating Factors) Market Size
What Is The Projected Market Size Of The Global G-CSF (Granulocyte Colony Stimulating Factors) Market And Its Growth Rate?
•The G-CSF market size has grown steadily in recent years and is projected to rise from $5.5 billion in 2024 to about $5.72 billion in 2025, marking a compound annual growth rate (CAGR) of 3.9%.
•Significant factors contributing to the historical growth of the market include an increase in cancer prevalence, economic growth in emerging markets, increased healthcare expenditure, rise in pharmaceutical R&D expenditure, and supportive government initiatives.
•The G-CSF market is expected to see further growth in the following years, estimated to reach $7.19 billion in 2029 at a CAGR of 5.9%.
•Increases in cancer prevalence, demand for prophylaxis G-CSF, healthcare expenditure, potential of emerging economies, technology advances, and high penetration of biosimilar drugs are expected to drive the market's growth in the forecast period.
What Is Driving The Growth In The G-CSF (Granulocyte Colony Stimulating Factors) Market?
The growing prevalence of cancer globally is a key factor driving the growing G-CSF market. Cancer is the second leading cause of death worldwide, with about 1 in 6 deaths being attributed to cancer. Accelerated recovery and reduced mortality from neutropenia after chemotherapy for cancer patients, facilitated by G-CSFs, is a major reason contributing to its rising market growth.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3466&type=smp
Who Are the Key Players Driving G-CSF (Granulocyte Colony Stimulating Factors) Market Growth?
•Amgen Inc.
•Coherus Biosciences Inc.
•Sandoz
•Biocon/Mylan
•Teva Pharmaceuticals Inc.
•Chugai Pharma
•Intalfarmaco Group
•Pfizer
•Sun Pharmaceutical Industries Limited
•BeyondSpring Inc.
•Kyowa Hakko Kirin Co. Ltd
•BioCad
•Stada Arzneimittel
•Dong-A Socio Group
•Dr. Reddy's Laboratories
•Celltrion Inc.
•Emcure Pharmaceuticals
•Accord Healthcare UK
•Intas Pharmaceuticals
•Spectrum Pharmaceuticals
•Apobiologix
•Apotex Inc.
•Eurofarma Laboratórios
•BIOPHARMA-MEA
•NeoTX
•AID Genomics Limited
•GlaxoSmithKline plc
•AstraZeneca
•Merck Sharp & Dohme Corp.
•Julphar
•Sanofi
•Novo Nordisk A/S
•Bayer
•Kitov Pharma Limited
•CureTech Ltd.
•Neopharma
•Cipla
What Are The Key Trends In The G-CSF (Granulocyte Colony Stimulating Factors) Market?
•Investment in R&D activities for the development of effective and innovative drugs.
•Increasing focus on M&A growth strategies.
•Emergence of strategic partnerships and new drug development activities.
•Focusing efforts towards the production of biosimilars for neutropenia treatment to improve revenues and product offerings.
What Are The Segments Of The Global G-CSF (Granulocyte Colony Stimulating Factors) Market?
•By Type: Pegfilgrastim, Lenograstim, Filgrastim, Other Types
•By Product: Tablet, Capsule, Other Products
•By Application: Oncological Diseases, Blood Disorders, Chronic And Autoimmune Disorders, Other Applications
Which Region Leads The G-CSF (Granulocyte Colony Stimulating Factors) Market?
North America had the largest market share for G-CSF in 2024, followed by regions like Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-book the Report for swift delivery:
https://www.thebusinessresearchcompany.com/report/g-csf-global-market-report
What Is Covered In The G-CSF (Granulocyte Colony Stimulating Factors) Market Global Market Report?
- Market Size Analysis: Analyze the G-CSF (Granulocyte Colony Stimulating Factors) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the G-CSF (Granulocyte Colony Stimulating Factors) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall G-CSF (Granulocyte Colony Stimulating Factors) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the G-CSF (Granulocyte Colony Stimulating Factors) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=3466&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Steady Growth Anticipated for Global G-CSF Market Fueled by Increasing Prevalence of Cancer and Demand for Innovative Drugs here
News-ID: 3837038 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Granulocyte
Pegylated Recombinant Human Granulocyte Colony Stimulating Factor Market Size An …
"The market for Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) is projected to reach approximately USD 4.1 billion in 2024, driven by increasing incidences of hematological malignancies and the rising demand for effective supportive care in cancer treatment. The market is expected to expand at a robust Compound Annual Growth Rate (CAGR) of 8.5% from 2025 to 2034, potentially reaching around USD 9 billion by the end of this…
G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2024: Strategies An …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The g-csf (granulocyte colony stimulating factors) market size has…
G-CSF (Granulocyte Colony Stimulating Factors) Market Analysis, Trends, Growth, …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2023 identifies increasing demand for prophylaxis granulocyte colony-stimulating factor as the major driver for the G-CSF market's growth in the forecast period. The prophylaxis with G-CSF decreases the occurrence of febrile neutropenia (FN), allowing…
Granulocyte Macrophage Colony Stimulating Factor Market Value Projected to Expan …
Granulocyte macrophage colony stimulating factor market is anticipated to grow at a significant CAGR during the forecast period. Granulocyte macrophage colony-stimulating factor, also called as CSF2 (colony stimulating factor 2), is a monomeric glycoprotein released by usual killer cells, T cells, mast cells, macrophages, fibroblasts, and endothelial cells that acts as a cytokine. The COVID-19 pandemic has significantly affected the global granulocyte macrophage colony stimulating factor market. Since this factor…
Rising Demand for Granulocyte Macrophage Colony Stimulating Factor Market Key Pl …
The global granulocyte macrophage colony stimulating factor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Granulocyte macrophage colony-stimulating factor, also called as CSF2 (colony stimulating factor 2), is a monomeric glycoprotein released by usual killer cells, T cells, mast cells, macrophages, fibroblasts, and endothelial cells that acts as a cytokine. The COVID-19 pandemic has significantly affected the global granulocyte macrophage colony stimulating factor market.…
Granulocyte-Colony Stimulating Factor Category to Dominate the Oncology Biosimil …
The demand for oncology biosimilar drugs has augmented in recent years. This is attributed to the rising prevalence of various types of cancers across the world. In addition, existing anti-cancer drugs in the pipeline are quite expensive, thus rendering them unaffordable to people in lower and middle income countries. As a consequence, the market for biosimilars has burgeoned.
For detailed insights on enhancing your product footprint, request for a sample…
